Doximity (NYSE:DOCS) Stock: Insider Kira Scherer Wampler Sells 2,000 Shares

Doximity, Inc. (NYSE:DOCS) Director Kira Wampler sold 2,000 shares of Doximity stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $32.89, for a total value of $65,780.00. Following the transaction, the director owned 27,923 shares in the company, valued at $918,387.47. This represents a 6.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Kira Scherer Wampler also recently made the following trade(s):

• On Thursday, October 1st, Kira Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $28.91, for a total value of $57,820.00.
• On Tuesday, August 25th, Kira Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $24.95, for a total value of $49,900.00.

Doximity Trading Down 3.9%

Shares of Doximity stock opened at $33.32 on Friday. The stock has a 50-day moving average price of $28.95 and a 200 day moving average price of $25.55. The company has a market cap of $5.94 billion, a P/E ratio of 39.20, a P/E/G ratio of 27.12 and a beta of 1.29. Doximity, Inc. has a 1 year low of $17.15 and a 1 year high of $64.55.

Doximity (NYSE:DOCS) last released its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.13. The company had revenue of $156.62 million for the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%. The company’s revenue was up 7.3% compared to the same quarter last year. During the same period last year, the firm earned $0.36 EPS. On average, equities analysts forecast that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Doximity

Several institutional investors have recently made changes to their positions in the company. Carmignac Gestion boosted its stake in shares of Doximity by 127.8% during the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after acquiring an additional 2,418,971 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Doximity by 24.7% in the 2nd quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after acquiring an additional 621,464 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Doximity by 29.4% in the 1st quarter. Renaissance Technologies LLC now owns 3,059,749 shares of the company’s stock valued at $71,292,000 after acquiring an additional 694,300 shares in the last quarter. Bank of America Corp DE lifted its holdings in Doximity by 31.8% in the 1st quarter. Bank of America Corp DE now owns 1,142,530 shares of the company’s stock worth $26,621,000 after purchasing an additional 275,650 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in Doximity by 0.4% in the 1st quarter. Bank of New York Mellon Corp now owns 1,040,534 shares of the company’s stock worth $24,244,000 after purchasing an additional 4,271 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Fiscal Q2 revenue was $174.5 million, ahead of the $170.8 million FactSet estimate, while EPS of $0.36 topped Zacks’ $0.34 consensus. Doximity also forecast Q3 revenue of $195–$196 million and FY2027 revenue of $678–$683 million, both above analyst expectations. Fiscal 2027 second-quarter results
• Positive Sentiment: Management cited record engagement, a 51% adjusted EBITDA margin, and adoption of its AI suite by more than 190 health systems. The company is expanding its offering with UpToDate and DoseCheck. Company results and management commentary
• Neutral Sentiment: Despite the earnings beat, EPS was down from $0.45 a year earlier. A report noted that DOCS stock fell after the sales beat, suggesting the positive results and guidance did not fully satisfy investors’ expectations. Doximity sales beat estimates but stock drops
• Negative Sentiment: Multiple law firms highlighted a pending securities class action and a November 16 lead-plaintiff deadline. The lawsuit alleges Doximity misrepresented the Newsfeed product’s contribution to revenue growth and its competitive position; these claims have not been established in court. The litigation adds uncertainty. Securities class action notice

Analyst Upgrades and Downgrades

DOCS has been the topic of a number of research analyst reports. Zacks Research raised shares of Doximity from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th. Barclays increased their target price on shares of Doximity from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Friday, August 21st. Piper Sandler reissued an “overweight” rating and set a $47.00 target price (up from $42.00) on shares of Doximity in a research note on Friday, August 7th. Weiss Ratings raised shares of Doximity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Finally, Wolfe Research upgraded shares of Doximity to an “outperform” rating in a report on Thursday, August 13th. Eight investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $30.73.

About Doximity

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.